Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
5PC5CcVMTMGYAeMe